The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nitric Oxide Therapy System Market Research Report 2024
Synopsis
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
The global Nitric Oxide Therapy System market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 46 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
This report aims to provide a comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitric Oxide Therapy System.
Report Scope
The Nitric Oxide Therapy System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitric Oxide Therapy System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitric Oxide Therapy System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Segment by Type
Protable System
Fixed System
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitric Oxide Therapy System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
The global Nitric Oxide Therapy System market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 46 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
This report aims to provide a comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitric Oxide Therapy System.
Report Scope
The Nitric Oxide Therapy System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitric Oxide Therapy System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitric Oxide Therapy System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Segment by Type
Protable System
Fixed System
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitric Oxide Therapy System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nitric Oxide Therapy System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protable System
1.2.3 Fixed System
1.3 Market by Application
1.3.1 Global Nitric Oxide Therapy System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nitric Oxide Therapy System Market Perspective (2019-2030)
2.2 Nitric Oxide Therapy System Growth Trends by Region
2.2.1 Global Nitric Oxide Therapy System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nitric Oxide Therapy System Historic Market Size by Region (2019-2024)
2.2.3 Nitric Oxide Therapy System Forecasted Market Size by Region (2025-2030)
2.3 Nitric Oxide Therapy System Market Dynamics
2.3.1 Nitric Oxide Therapy System Industry Trends
2.3.2 Nitric Oxide Therapy System Market Drivers
2.3.3 Nitric Oxide Therapy System Market Challenges
2.3.4 Nitric Oxide Therapy System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nitric Oxide Therapy System Players by Revenue
3.1.1 Global Top Nitric Oxide Therapy System Players by Revenue (2019-2024)
3.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Players (2019-2024)
3.2 Global Nitric Oxide Therapy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nitric Oxide Therapy System Revenue
3.4 Global Nitric Oxide Therapy System Market Concentration Ratio
3.4.1 Global Nitric Oxide Therapy System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nitric Oxide Therapy System Revenue in 2023
3.5 Nitric Oxide Therapy System Key Players Head office and Area Served
3.6 Key Players Nitric Oxide Therapy System Product Solution and Service
3.7 Date of Enter into Nitric Oxide Therapy System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nitric Oxide Therapy System Breakdown Data by Type
4.1 Global Nitric Oxide Therapy System Historic Market Size by Type (2019-2024)
4.2 Global Nitric Oxide Therapy System Forecasted Market Size by Type (2025-2030)
5 Nitric Oxide Therapy System Breakdown Data by Application
5.1 Global Nitric Oxide Therapy System Historic Market Size by Application (2019-2024)
5.2 Global Nitric Oxide Therapy System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nitric Oxide Therapy System Market Size (2019-2030)
6.2 North America Nitric Oxide Therapy System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nitric Oxide Therapy System Market Size by Country (2019-2024)
6.4 North America Nitric Oxide Therapy System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nitric Oxide Therapy System Market Size (2019-2030)
7.2 Europe Nitric Oxide Therapy System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nitric Oxide Therapy System Market Size by Country (2019-2024)
7.4 Europe Nitric Oxide Therapy System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nitric Oxide Therapy System Market Size (2019-2030)
8.2 Asia-Pacific Nitric Oxide Therapy System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nitric Oxide Therapy System Market Size by Region (2019-2024)
8.4 Asia-Pacific Nitric Oxide Therapy System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nitric Oxide Therapy System Market Size (2019-2030)
9.2 Latin America Nitric Oxide Therapy System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nitric Oxide Therapy System Market Size by Country (2019-2024)
9.4 Latin America Nitric Oxide Therapy System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nitric Oxide Therapy System Market Size (2019-2030)
10.2 Middle East & Africa Nitric Oxide Therapy System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2019-2024)
10.4 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bellerophon Therapeutics
11.1.1 Bellerophon Therapeutics Company Detail
11.1.2 Bellerophon Therapeutics Business Overview
11.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Introduction
11.1.4 Bellerophon Therapeutics Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.1.5 Bellerophon Therapeutics Recent Development
11.2 BOC Healthcare
11.2.1 BOC Healthcare Company Detail
11.2.2 BOC Healthcare Business Overview
11.2.3 BOC Healthcare Nitric Oxide Therapy System Introduction
11.2.4 BOC Healthcare Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.2.5 BOC Healthcare Recent Development
11.3 Dan Hammer Health
11.3.1 Dan Hammer Health Company Detail
11.3.2 Dan Hammer Health Business Overview
11.3.3 Dan Hammer Health Nitric Oxide Therapy System Introduction
11.3.4 Dan Hammer Health Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.3.5 Dan Hammer Health Recent Development
11.4 EKU Elektronik GmbH
11.4.1 EKU Elektronik GmbH Company Detail
11.4.2 EKU Elektronik GmbH Business Overview
11.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Introduction
11.4.4 EKU Elektronik GmbH Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.4.5 EKU Elektronik GmbH Recent Development
11.5 GeNO LLC
11.5.1 GeNO LLC Company Detail
11.5.2 GeNO LLC Business Overview
11.5.3 GeNO LLC Nitric Oxide Therapy System Introduction
11.5.4 GeNO LLC Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.5.5 GeNO LLC Recent Development
11.6 International Biomedical
11.6.1 International Biomedical Company Detail
11.6.2 International Biomedical Business Overview
11.6.3 International Biomedical Nitric Oxide Therapy System Introduction
11.6.4 International Biomedical Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.6.5 International Biomedical Recent Development
11.7 SLE
11.7.1 SLE Company Detail
11.7.2 SLE Business Overview
11.7.3 SLE Nitric Oxide Therapy System Introduction
11.7.4 SLE Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.7.5 SLE Recent Development
11.8 Mallinckrodt Pharmaceuticals
11.8.1 Mallinckrodt Pharmaceuticals Company Detail
11.8.2 Mallinckrodt Pharmaceuticals Business Overview
11.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Introduction
11.8.4 Mallinckrodt Pharmaceuticals Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.8.5 Mallinckrodt Pharmaceuticals Recent Development
11.9 Praxair,
11.9.1 Praxair, Company Detail
11.9.2 Praxair, Business Overview
11.9.3 Praxair, Nitric Oxide Therapy System Introduction
11.9.4 Praxair, Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.9.5 Praxair, Recent Development
11.10 Vapotherm
11.10.1 Vapotherm Company Detail
11.10.2 Vapotherm Business Overview
11.10.3 Vapotherm Nitric Oxide Therapy System Introduction
11.10.4 Vapotherm Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.10.5 Vapotherm Recent Development
11.11 Linde Group
11.11.1 Linde Group Company Detail
11.11.2 Linde Group Business Overview
11.11.3 Linde Group Nitric Oxide Therapy System Introduction
11.11.4 Linde Group Revenue in Nitric Oxide Therapy System Business (2019-2024)
11.11.5 Linde Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
